Abstract: The present invention regards use of a bacterial superantigen for administration onto the mucous membrane of a domestic non-human mammal for the prevention of inflammatory disorder, such as allergies, autoimmune and inflammatory diseases.
Type:
Grant
Filed:
February 5, 2013
Date of Patent:
June 28, 2016
Assignee:
Premune AB
Inventors:
Ingegerd Adlerberth, Anna Rudin, Agnes Wold